Celtarys exclusive fluorescent ligands for cannabinoid receptors used to analyze binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Celtarys Research awarded as “Best Business Idea” by the Galician Biotechnology Cluster Bioga
21 December 2021

Don’t miss the new article by Dr. Gemma Navarro and Dr. Rafael Franco about cannabinoid CB1 and CB2 receptors signaling. They have successfully used CELT-335, one of our fluorescent CB1/CB2 receptor ligands, to perform binding competition assays avoiding the use of radioactivity.

See full article: https://www.sciencedirect.com/science/article/pii/S1043661821005545?via%3Dihub